78Indexed trials
Market Rank #29 · Evidence Tier A
Finland
Neuroscience Intelligence
Finland neuroscience intelligence: 78 indexed trials, 19 institutions, research score 29.50.
19Recruiting
19Research institutions
29.5Research score
Evidence profile
46Sponsors
17Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 30 · ML priority 30 · Confidence 85 · Evidence 29.5
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
alzheimers19trials
parkinsons12trials
epilepsy11trials
stroke8trials
other_neurology4trials
schizophrenia4trials
depression3trials
other_psychiatry2trials
sleep_disorders2trials
pain_neuropathy2trials
Leading indexed sponsors
Merck Sharp & Dohme LLC6trials
Boehringer Ingelheim5trials
Hoffmann-La Roche5trials
Bayer4trials
Pfizer3trials
Helsinki University Central Hospital3trials
Novo Nordisk A/S3trials
Bristol-Myers Squibb2trials
Kuopio University Hospital2trials
H. Lundbeck A/S2trials